SCHEMBL25823856

SCHEMBL25823856

CCOC(=O)CCCCCCCCCCOc1cc(C)c(OCCCCCCCCCCC(=O)OCC)c(C)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
ALDH1A1 P00352 2/20 0.41
ALOX15 P16050 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
DGKA P23743 1/20 0.40
CYP1A2 P05177 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
FFAR1 O14842 1/20 0.39
PDK2 Q15119 1/20 0.39
BRD4 O60885 1/20 0.39
TNF P01375 2/20 0.39
ALDH2 P05091 1/20 0.38
MAOA P21397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7163428 0.78 SRC (0.43) THRATHRBALDH1A1ALOX15TDP1
SCHEMBL7799040 0.77 MEN1 (0.43) ALDH1A1TSHRCYP1A2MEN1KMT2A
SCHEMBL7799043 0.77 ALDH1A1 (0.56) ALDH1A1TSHRCYP1A2MEN1KMT2A
SCHEMBL12363878 0.77 DGKA (0.54) TSHRDGKATNF
SCHEMBL28645068 0.75 ALDH1A1 (0.42) ALDH1A1ALOX15TDP1CYP3A4TSHR
SCHEMBL5335009 0.75 LMNA (0.49) THRATHRBALDH1A1ALOX15TDP1
SCHEMBL4611955 0.75 ALDH1A1 (0.42) ALDH1A1ALOX15TDP1CYP3A4TSHR
SCHEMBL22091809 0.75 CYP4F2 (0.56) ALDH1A1CYP3A4CYP1A2CYP4F2CYP4A11
SCHEMBL22091914 0.75 CYP4F2 (0.56) ALDH1A1CYP3A4CYP1A2CYP4F2CYP4A11
SCHEMBL22091832 0.75 CYP4F2 (0.56) ALDH1A1CYP3A4CYP1A2CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212136-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT FUJIFILM CORPORATION (JP) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212136-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT TERB1, RER1, LARP1 THRA 1650/4885THRB 2874/4885ALDH1A1 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.